Creator: Nemaura Medical
Launch date: Expected 2019
SugarBEAT is bucking the CGM industry trend of longer sensor wear times. Instead, it uses an adhesive skin patch that gets changed daily, which sits under a rechargeable transmitter. The transmitter delivers the sensor’s results to a smartphone, tablet, or watch, or to an optional stand-alone reader.
The adhesive patch works differently from other CGM sensors, according to creator Nemaura Medical. It passes a low-level electrical current across the skin, which draws glucose molecules from the interstitial fluid beneath the skin into a chamber in the patch, where it can be measured by the transmitter device.
The company asserts that SugarBEAT will offer users greater flexibility, since it can be worn on nonconsecutive days — unlike other CGM systems that require 10 to 14 days of continuous wearing. It also aims to make the system cheaper than its competitors, with costs comparable to traditional fingerstick tests.
SugarBEAT is expected to launch in the United Kingdom in 2018, followed shortly by a wider European launch. In the United States, clinical trials have begun as part of the FDA’s requirements, with an expected submission for approval in the first half of 2019.